BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma

A BioNTech-led team designed a cocktail of mRNAs that instruct cells to produce four cancer-fighting molecules.

Smart dental implants

Geelsu Hwang of the School of Dental Medicine and colleagues are developing a smart dental implant that resists bacterial growth and generates its own electricity through chewing and brushing to power

iECURE emerges with $50M to search for ‘holy grail’ and ‘untapped frontier’ of gene editing

The biotech will use the funds for a slate of gene insertion programs for liver disorders out of the lab of gene therapy pioneer Jim Wilson, M.D., Ph.D. at Penn.

Penn scientists win $3 million Breakthrough Prize for RNA research that enabled COVID-19 vaccines

Sixteen years after their research at Penn paved the way for billions to be vaccinated against COVID-19, two scientists from Penn have been honored with the Breakthrough Prize.

Philly life science firms raised more than $777M in the first half of 2021 alone

According to a new CBRE report, life science firms are on pace for a record year. Plus, a look at lab space occupancy.

Penn Medicine and Wharton Social Impact Initiative Launch New $5 Million Investment Initiative for Businesses that Improve Health of Philadelphians

Three start-up companies will be the first to receive investment from the Fund for Health, a joint partnership between Penn Medicine and the Wharton Social Impact Initiative.

Penn to play key role in the inaugural NSF Mid-Atlantic I-Corps Hub to advance entrepreneurship and technology commercialization training

PCI is proud to announce that Penn is one of the schools chosen to participate in the National Science Foundation’s new innovative I-Corps Hub initiative.

Penn mRNA researchers Drew Weissman and Katalin Karikó awarded the 2021 Albany Prize

The award, one of the largest in medicine and science in the U.S., has been given for the last 20 years by Albany Medical Center to those who have altered and positively impacted the course

COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval

The U.S. FDA has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists at Penn.

Filter

Success Stories

Highlights of the PCI news focused on Penn commercialization accomplishments

All Success Stories
Skip to content